207 related articles for article (PubMed ID: 34884938)
1. Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1.
Becker A; Götz C; Montenarh M; Philipp SE
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884938
[TBL] [Abstract][Full Text] [Related]
2. Control of Insulin Release by Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels.
Becker A; Mannebach S; Mathar I; Weissgerber P; Freichel M; Loodin AP; Fecher-Trost C; Belkacemi A; Beck A; Philipp SE
Cell Physiol Biochem; 2020 Nov; 54(6):1115-1131. PubMed ID: 33166100
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase CK2 Controls Ca
Scheuer R; Philipp SE; Becker A; Nalbach L; Ampofo E; Montenarh M; Götz C
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630015
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction via TRPM3 channels in pancreatic β-cells.
Thiel G; Müller I; Rössler OG
J Mol Endocrinol; 2013 Jun; 50(3):R75-83. PubMed ID: 23511953
[TBL] [Abstract][Full Text] [Related]
5. Ca
Przibilla J; Dembla S; Rizun O; Lis A; Jung M; Oberwinkler J; Beck A; Philipp SE
Cell Calcium; 2018 Jul; 73():40-52. PubMed ID: 29880196
[TBL] [Abstract][Full Text] [Related]
6. Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.
Klose C; Straub I; Riehle M; Ranta F; Krautwurst D; Ullrich S; Meyerhof W; Harteneck C
Br J Pharmacol; 2011 Apr; 162(8):1757-69. PubMed ID: 21198543
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Signal-Regulated Protein Kinase, c-Jun N-Terminal Protein Kinase, and Calcineurin Regulate Transient Receptor Potential M3 (TRPM3) Induced Activation of AP-1.
Lesch A; Rössler OG; Thiel G
J Cell Biochem; 2017 Aug; 118(8):2409-2419. PubMed ID: 28112420
[TBL] [Abstract][Full Text] [Related]
8. TRPM3 channels provide a regulated influx pathway for zinc in pancreatic beta cells.
Wagner TF; Drews A; Loch S; Mohr F; Philipp SE; Lambert S; Oberwinkler J
Pflugers Arch; 2010 Sep; 460(4):755-65. PubMed ID: 20401728
[TBL] [Abstract][Full Text] [Related]
9. Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release.
Held K; Kichko T; De Clercq K; Klaassen H; Van Bree R; Vanherck JC; Marchand A; Reeh PW; Chaltin P; Voets T; Vriens J
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1363-72. PubMed ID: 25733887
[TBL] [Abstract][Full Text] [Related]
10. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
Zhao S; Yudin Y; Rohacs T
Elife; 2020 Apr; 9():. PubMed ID: 32343227
[TBL] [Abstract][Full Text] [Related]
12. Stimulation-dependent gating of TRPM3 channel in planar lipid bilayers.
Uchida K; Demirkhanyan L; Asuthkar S; Cohen A; Tominaga M; Zakharian E
FASEB J; 2016 Mar; 30(3):1306-16. PubMed ID: 26655382
[TBL] [Abstract][Full Text] [Related]
13. Identification and classification of a new TRPM3 variant (γ subtype).
Uchida K; Fukuta N; Yamazaki J; Tominaga M
J Physiol Sci; 2019 Jul; 69(4):623-634. PubMed ID: 31011981
[TBL] [Abstract][Full Text] [Related]
14. A Cataract-Causing Mutation in the TRPM3 Cation Channel Disrupts Calcium Dynamics in the Lens.
Zhou Y; Bennett TM; Ruzycki PA; Guo Z; Cao YQ; Shahidullah M; Delamere NA; Shiels A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334649
[TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential melastatin-3 (TRPM3)-induced activation of AP-1 requires Ca2+ ions and the transcription factors c-Jun, ATF2, and ternary complex factor.
Lesch A; Hui X; Lipp P; Thiel G
Mol Pharmacol; 2015 Apr; 87(4):617-28. PubMed ID: 25576487
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction of pregnenolone sulfate in insulinoma cells: activation of Egr-1 expression involving TRPM3, voltage-gated calcium channels, ERK, and ternary complex factors.
Mayer SI; Müller I; Mannebach S; Endo T; Thiel G
J Biol Chem; 2011 Mar; 286(12):10084-96. PubMed ID: 21257751
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of a protein domain indispensable for function of transient receptor potential melastatin 3 (TRPM3) ion channels.
Frühwald J; Camacho Londoño J; Dembla S; Mannebach S; Lis A; Drews A; Wissenbach U; Oberwinkler J; Philipp SE
J Biol Chem; 2012 Oct; 287(44):36663-72. PubMed ID: 22961981
[TBL] [Abstract][Full Text] [Related]
18. Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels.
Majeed Y; Agarwal AK; Naylor J; Seymour VA; Jiang S; Muraki K; Fishwick CW; Beech DJ
Br J Pharmacol; 2010 Sep; 161(2):430-41. PubMed ID: 20735426
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
20. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.
Rossi M; Ruiz de Azua I; Barella LF; Sakamoto W; Zhu L; Cui Y; Lu H; Rebholz H; Matschinsky FM; Doliba NM; Butcher AJ; Tobin AB; Wess J
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6818-24. PubMed ID: 26598688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
